Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Mutual Funds Keep Buying Up Google, These 2 Other Big Caps

Google stock is a mutual fund favorite and is near a buy point. Two other leading growth stocks top the list of fund favorites.

Investors Business Daily

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal stock plummeted Wednesday on detailed results from a study of Eli Lilly's weight-loss drug in patients with a serious liver disease.

Investors Business Daily

Alphabet Picks Eli Lilly Executive Anat Ashkenazi As New CFO

Alphabet Picks Eli Lilly Executive Anat Ashkenazi As New CFO

Google-parent Alphabet announced that its new chief financial officer will be Anat Ashkenazi, currently an executive at pharmaceutical company Eli Lilly.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight

As Nvidia stock takes aim at another record high and market-cap dominance, AMD and TSM set up alongside two top drugmakers.

Investors Business Daily

3 Pharma Stocks Poised for Big Returns This Summer

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs and the incorporation of cutting-edge technologies into drug manufacturing. Hence, pharma stocks Eli Lilly (LLY), Green Thumb Industries (GTBIF), and Supernus Pharmaceuticals (SUPN) might be worth buying for returns this summer. Read more….

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

Investors Business Daily

One Ozempic patient reveals major drug-powered weight loss truths

As medicines for losing weight become more widely accessed and affordable, people are discussing their experiences.

inkl

Read news from The Economist, FT, and more,
with one subscription

Do Wall Street Analysts Like Eli Lilly Stock?

Do Wall Street Analysts Like Eli Lilly Stock?

Eli Lilly stock has outperformed the broader market over the past year, and Wall Street analysts remain optimistic about the stock’s prospect.

Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds

Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds

Costco stock is in a buy zone ahead of the earnings report Thursday. Mutual funds like this stock and a few others.

Investors Business Daily

Dow Jones Futures Fall, But Nvidia Leads Techs Higher; 7 Stocks Near Buy Points

Dow Jones Futures Fall, But Nvidia Leads Techs Higher; 7 Stocks Near Buy Points

The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.

Investors Business Daily

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?

The pharmaceutical market is poised for rapid expansion due to rising global medical needs and increasing integration of technologies in drug discovery and development. Amid this, let’s analyze Eli Lilly (LLY) and Novo Nordisk (NVO) to determine which pharma stock will drive long-term profits in 2024. Read more to find…

Eight Massive ETFs With Billions In Assets Are Beating The S&P 500

Eight Massive ETFs With Billions In Assets Are Beating The S&P 500

You don't need to gamble on tiny ETFs with scant assets to beat the S&P 500. Turns out you can do it just fine with massive ones.

Investors Business Daily

Weight-loss drugs: How low costs, easy access change the game now

Weight-loss drugs: How low costs, easy access change the game now

Pharmaceutical CEO George Hampton discusses anti-obesity medications and the quickly moving acceleration of their affordability and accessibility.

It's Time for Over-the-Counter Ozempic

There's an easy way to lower the cost of next-generation weight-loss drugs.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall As Target Tumbles; Nvidia Looms Over Stock Market

The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?

Investors Business Daily

IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High

Eli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising test results for a Crohn's treatment.

Investors Business Daily

Magnificent Seven? Just Two Members Clear This Bar

Ultimately, earnings drive share prices. Only two Magnificent Seven stocks, and a third megacap, meet this triple-25% growth standard.

Investors Business Daily

Dow Jones Futures Rise On Cisco, Walmart After Market Rally Hits Highs, Nvidia Breaks Out

Futures rose on Cisco and Walmart. On Wednesday, the Dow, S&P 500 and Nasdaq hit record highs, with Nvidia leading new buys.

Get all your
news in one place.

100’s of premium titles.
One news app.

1 'Strong Buy' Dividend Stock to Buy and Hold

Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects.

Investors Business Daily

How A Top Fund Beats The Market By Owning Future Leaders

Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities, isn't interested in blue-chip stars of yesteryear.

Investors Business Daily

Mutual Funds Can't Get Enough Amazon, Broadcom

Amazon stock climbs back near highs and is a mutual funds favorite. Shares gained more than 23% this year. Broadcom stock tests a key level.

Analyst unveils Amgen stock price target after weight-loss drug data

Here's what could happen next to Amgen shares.

Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.

Analysts reveal Eli Lilly stock price targets after earnings

Here's what could happen next to Eli Lilly shares.

What is behind the insulin shortage in the US?

Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.

1 … 6 7 8 9

People

Mangeet Kaur BounsMangeet

Christopher Waller

Todd Rosenbluth

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

234,631 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play